{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:17:57Z","timestamp":1789676277086,"version":"4.0.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.dmpk.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T12:18:23Z","timestamp":1418818703000},"page":"160-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities"],"prefix":"10.1016","volume":"30","author":[{"given":"Ikuo","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bouillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikoe","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2014.12.002_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00044011-200424040-00001","article-title":"Overview of the clinical pharmacokinetics of oxcarbazepine","volume":"24","author":"Flesch","year":"2004","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.dmpk.2014.12.002_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","article-title":"A\u00a0double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy","volume":"3","author":"Dam","year":"1989","journal-title":"Epilepsy Res"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.dmpk.2014.12.002_bib3","first-page":"73","article-title":"Pharmacokinetic and metabolic features of oxcarbazepine and their clinical significance: comparison with carbamazepine","volume":"5","author":"Faigle","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.dmpk.2014.12.002_bib4","first-page":"S14","article-title":"Oxcarbazepine: pharmacokinetic interactions and their clinical relevance","volume":"35","author":"Baruzzi","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.dmpk.2014.12.002_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(94)90787-0","article-title":"Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures","volume":"271","author":"Wamil","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.dmpk.2014.12.002_bib6","first-page":"S5","article-title":"Oxcarbazepine: mechanisms of action","volume":"35","author":"McLean","year":"1994","journal-title":"Epilepsia"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.dmpk.2014.12.002_bib7","first-page":"S47","article-title":"Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action","volume":"35","author":"Schmutz","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.dmpk.2014.12.002_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1528-1157.1995.tb00958.x","article-title":"Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents","volume":"36","author":"Stefani","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.dmpk.2014.12.002_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0009-9236(03)00124-3","article-title":"Pharmacokinetic drug interactions in children taking oxcarbazepine","volume":"74","author":"Sallas","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2014.12.002_bib10","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1212\/WNL.54.12.2237","article-title":"Adjunctive therapy with oxcarbazepine in children with partial seizures","volume":"54","author":"Glauser","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.dmpk.2014.12.002_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J"},{"key":"10.1016\/j.dmpk.2014.12.002_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.1994.tb04234.x","article-title":"A\u00a0double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients","volume":"37","author":"McKee","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2014.12.002_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2125.1993.tb00378.x","article-title":"The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid","volume":"36","author":"Tartara","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2014.12.002_bib14","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1038\/psp.2013.6","article-title":"Modeling and simulation as a tool to bridge efficacy and safety data in special populations","volume":"2","author":"Harnisch","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436714000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436714000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:51:52Z","timestamp":1761162712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436714000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1347436714000238"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2014.12.002","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}